Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-19

Clinical Trial Update: Microneedle Treatment of Chronic Phase Peyronie's Disease: A Pilot Clinical Trial [Phase 1]

View source ↗

Summary

Phase 1 pilot clinical trial evaluating microneedle treatment for chronic Peyronie's disease, currently enrolling by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Microneedle treatment for Peyronie's disease

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Peyronie's Disease | Phase 1 | Status: ENROLLING_BY_INVITATION